Quercetin Inhibits Lef1 and Resensitizes Docetaxel-Resistant Breast Cancer Cells

Drug resistance is a major problem for breast cancer patients. Docetaxel is an anti-mitotic agent that serves as first line of treatment in metastatic breast cancer, however it is susceptible to cellular drug resistance. Drug-resistant cells are able to spread during treatment, leading to treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Prieto-Vila, Marta, Shimomura, Iwao, Kogure, Akiko, Usuba, Wataru, Takahashi, Ryou-u, Ochiya, Takahiro, Yamamoto, Yusuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321307/
https://www.ncbi.nlm.nih.gov/pubmed/32492961
http://dx.doi.org/10.3390/molecules25112576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321307/
https://www.ncbi.nlm.nih.gov/pubmed/32492961
http://dx.doi.org/10.3390/molecules25112576

Ejemplares similares